|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Operating activities | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities | |||||
| Provision for loan losses | |||||
| Depreciation and amortization of premises and equipment | |||||
| Net amortization on securities | |||||
| Amortization of intangible assets | |||||
| Amortization of operating lease right-of-use assets | |||||
| Excess tax benefit on stock-based compensation | |||||
| Stock-based compensation expense | |||||
| Bank owned life insurance income | |||||
| Amortization of subordinated debt issuance costs | |||||
| Discount on repurchase of subordinated debt | |||||
| Proceeds from sale of loans held for sale | |||||
| Originations of loans held for sale | |||||
| Net gain on sale of loans held for sale | |||||
| Net security (gains) losses | |||||
| Net gains on sale of other real estate owned | |||||
| Impairment of a minority interest equity investment | |||||
| Net deferred income tax expense (benefit) | |||||
| Net change in other assets and other liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities | |||||
| Net cash provided by (used in) acquisitions | |||||
| Securities available for sale: | |||||
| Proceeds from maturities, calls and principal paydowns | |||||
| Proceeds from sales | |||||
| Purchases | |||||
| Securities held to maturity: | |||||
| Proceeds from maturities, calls and principal paydowns | |||||
| Purchases | |||||
| Equity securities: | |||||
| Proceeds from calls | |||||
| Proceeds from sales | |||||
| Purchases | |||||
| Other: | |||||
| Net decrease (increase) in loans | |||||
| Proceeds from Federal Home Loan Bank stock redemption | |||||
| Purchases of Federal Reserve Bank and Federal Home Loan Bank stock | |||||
| Proceeds from settlement of bank owned life insurance | |||||
| Purchases of bank owned life insurance | |||||
| Purchases of premises and equipment, net | |||||
| Proceeds from sales of other real estate owned | |||||
| Net cash provided by (used in) investing activities | |||||
| Financing activities | |||||
| Net increase in deposits | |||||
| Net decrease in short-term borrowings | |||||
| Redemption of subordinated debt | |||||
| Proceeds from long-term debt | |||||
| Repayments of long-term debt | |||||
| Proceeds from the issuance of shares to employee and other stock plans | |||||
| Cash paid by employer for tax-withholding on stock issuance | |||||
| Purchase of treasury stock | |||||
| Cash dividends | |||||
| Net cash (used in) provided by financing activities | |||||
| Net (decrease) increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental disclosure of cash flow information | |||||
| Cash paid during the year for: | |||||
| Interest expense | |||||
| Income taxes paid, net of refund | |||||
| Noncash investing activities: | |||||
| Loans transferred to other real estate owned | |||||
| Acquisitions: | |||||
| Fair value of assets acquired, excluding acquired cash and goodwill | |||||
| Fair value of liabilities assumed | |||||
| Common stock issued | |||||
Loading...